Search

Your search keyword '"Ferraro, Daniela"' showing total 254 results

Search Constraints

Start Over You searched for: Author "Ferraro, Daniela" Remove constraint Author: "Ferraro, Daniela"
254 results on '"Ferraro, Daniela"'

Search Results

Catalog

Books, media, physical & digital resources

3. Prostate Cancer

10. Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study

11. Immunohistochemical ERG positivity is associated with decreased PSMA expression and lower visibility in corresponding [68Ga]Ga-PSMA-11 PET scans of primary prostate cancer.

13. Immunohistochemical ERG positivity is associated with decreased PSMA expression and lower visibility in corresponding [$^{68}$Ga]Ga-PSMA-11 PET scans of primary prostate cancer

16. Oncologie: ce qui a changé en 2023

19. Clinical impact of 68Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction

25. Development and external validation of a multivariable [$^{68}$Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer

30. Can Dynamic Whole-Body FDG PET Imaging Differentiate between Malignant and Inflammatory Lesions?

32. Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer.

33. 68 Ga-PSMA-11 PET/MRI versus multiparametric MRI in men referred for prostate biopsy: primary tumour localization and interreader agreement

34. Infiltrative growth pattern of prostate cancer is associated with lower uptake on PSMA PET and reduced diffusion restriction on mpMRI

35. Hot needles can confirm accurate lesion sampling intraoperatively using [ 18 F]PSMA-1007 PET/CT-guided biopsy in patients with suspected prostate cancer

36. Can Dynamic Whole-Body FDG PET Imaging Differentiate between Malignant and Inflammatory Lesions?

37. Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate- to high-risk patients

38. Additional file 1 of 68Ga-PSMA-11 PET/MRI versus multiparametric MRI in men referred for prostate biopsy: primary tumour localization and interreader agreement

39. Hot needles can confirm accurate lesion sampling intraoperatively using [18F]PSMA-1007 PET/CT-guided biopsy in patients with suspected prostate cancer

40. A pilot study on lung cancer detection based on regional metabolic activity distribution in digital low-dose 18F-FDG PET

41. Whole-body parametric [ 18 F]-FDG PET/CT improves interpretation of a distant lesion as venous embolus in a lung cancer patient

42. Diagnostic performance of 68 Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study

43. 68 Ga-PSMA-11 PET imaging in patients with ongoing androgen deprivation therapy for advanced prostate cancer

46. ENEL Energy Management Evolution in a growing complexity of the Italian market context

48. $^{68}$Ga-PSMA-11 PET imaging in patients with ongoing androgen deprivation therapy for advanced prostate cancer

49. When SUV Matters: FDG PET/CT at Baseline Correlates with Survival in Soft Tissue and Ewing Sarcoma

50. What's behind 68 Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patterns